Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.
Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall
The British molecular diagnostics firm also announced executive appointments for both the US and European operations.
The firms will develop tests to run on Enigma's ML platform. As part of the alliance, GSK will make an equity investment in the molecular diagnostics startup.
Enigma Diagnostics gained access to two Roche patents for use in its multiplex PCR tests for human and animal diseases.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.